Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

Congresses

ECP ( Cell Pathology)

2026/09/12-2026/09/16

Stockholm, Sweden

The 38th European Congress of Pathology (ECP 2026) will be held in Stockholm, Sweden, from 12 to 16 September 2026, at the Stockholmsmässan congress centre. Organized by the European Society of Pathology (ESP) in collaboration with the Swedish Society of Pathology, this event is the premier gathering for the global pathology community, expected to attract over 5,000 pathologists, clinicians, molecular biologists, and researchers.

Under the theme "Innovation Driving Excellence in Pathology," the congress will explore the rapid evolution of diagnostic medicine. The scientific programme focuses on the integration of cutting-edge technologies, such as digital pathology and artificial intelligence, into daily clinical practice. Attendees will participate in a wide range of sessions, including state-of-the-art lectures, interactive slide seminars, and symposia covering various organ-based subspecialties. Beyond the technical sessions, ECP 2026 offers an essential platform for international networking and professional development, fostering the multidisciplinary dialogue necessary to advance precision medicine and improve patient care worldwide.

DATE

2026/09/12-2026/09/16

LOCATION

Stockholm, Sweden

THERAPEUTIC AREAS

Cell Pathology

SPONSORSHIP

-

DOWNLOAD

-

WHERE TO FIND US

-